PHARMACOKINETICS (PK) OF HZN-825, A SMALL MOLECULE SELECTIVE ANTAGONIST OF LPAR1, AND THE EFFECT OF FOOD IN HEALTHY ADULT SUBJECTS

被引：0
|
作者：
Song, Y. [1 ]
Ali, F. [2 ]
Ye, Z. [2 ]
Zarzoso, J. [1 ]
Rogowski, J. [1 ]
Sun, Y. [1 ]
Xin, Y. [1 ]
机构：
[1] Horizon Therapeut, San Francisco, CA USA
[2] Horizon Therapeut, Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-071
引用
收藏
页码：S66 / S67
页数：2
相关论文
共 50 条
  • [1] THE EFFECT OF FOOD AND ANTACID ON PHARMACOKINETICS (PK) OF SCH 530348 IN HEALTHY SUBJECTS
    Reyderman, L.
    Kosoglou, T.
    Tseng, J.
    Xuan, F.
    Schiller, J.
    Cutler, D. L.
    Kim, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S21 - S21
  • [2] The Absence of a Clinically Significant Effect of Food on the Single Dose Pharmacokinetics of Vorapaxar, a PAR-1 Antagonist, in Healthy Adult Subjects
    Behm, Martin O.
    Kosoglou, Teddy
    Miltenburg, Andre M. M.
    Li, Jing
    Statkevich, Paul
    Johnson-Levonas, Amy O.
    Martinho, Monika
    Fackler, Paul
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (04): : 310 - 315
  • [3] EFFECT OF FOOD ON PHARMACOKINETICS AND SAFETY OF DA-8010, A NOVEL SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST, IN HEALTHY SUBJECTS
    Khwarg, J.
    Yang, E.
    Chung, W.
    Park, S.
    Jang, I
    Cho, J.
    Ryu, C.
    Lee, D.
    Lee, M.
    Kim, H.
    Lee, S.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S29 - S30
  • [4] Evaluation of Food Effect on the Pharmacokinetics of Velufenacin, a New Muscarinic Receptor Antagonist, in Healthy Subjects
    Khwarg, Juyoung
    Chung, Woo Kyung
    Lee, Soyoung
    Yang, Eunsol
    Ryu, Chaelim
    Lee, Dae Young
    Lee, Min Jung
    Jang, In-Jin
    Yu, Kyung-Sang
    Lee, Seunghwan
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (02): : 128 - 133
  • [5] EFFECT OF FOOD AND THE PROTON PUMP INHIBITOR (PPI) ESOMEPRAZOLE ON THE PHARMACOKINETICS (PK) OF ALECTINIB, A HIGHLY SELECTIVE ALK INHIBITOR, IN HEALTHY SUBJECTS
    Morcos, P. N.
    Dall, G. C.
    Parrott, N. J.
    Bogman, K.
    Guerini, E.
    Zeaiter, A.
    Martin-Facklam, M.
    Phipps, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S62 - S63
  • [6] Pharmacokinetics of Fipaxalparant, a Small-Molecule Selective Negative Allosteric Modulator of Lysophosphatidic Acid Receptor 1, and the Effect of Food in Healthy Volunteers
    Song, Yang
    Ali, Farah N.
    Ye, Zhan
    Zarzoso, Jennifer
    Rogowski, John
    Sun, Yajing
    Xin, Yan
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (07): : 819 - 827
  • [7] Effect of Food and Esomeprazole on the Pharmacokinetics of Alectinib, a Highly Selective ALK Inhibitor, in Healthy Subjects
    Morcos, Peter N.
    Guerini, Elena
    Parrott, Neil
    Dall, Georgina
    Blotner, Steven
    Bogman, Katrijn
    Sturm, Carolina
    Balas, Bogdana
    Martin-Facklam, Meret
    Phipps, Alex
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (04): : 388 - 397
  • [8] The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects
    Bruce E. Miller
    Sunil Mistry
    Kevin Smart
    Paul Connolly
    Donald C. Carpenter
    Hiran Cooray
    Jackie C. Bloomer
    Ruth Tal-Singer
    Aili L. Lazaar
    BMC Pharmacology and Toxicology, 16
  • [9] The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) - a selective CXCR2 antagonist - in healthy adult subjects
    Miller, Bruce E.
    Mistry, Sunil
    Smart, Kevin
    Connolly, Paul
    Carpenter, Donald C.
    Cooray, Hiran
    Bloomer, Jackie C.
    Tal-Singer, Ruth
    Lazaar, Aili L.
    BMC PHARMACOLOGY & TOXICOLOGY, 2015, 16
  • [10] Pharmacokinetics (PK) of Adenosine A1 Receptor Antagonist BG9928 in Healthy Subjects, Elderly Subjects, and Subjects with Severe Renal Insufficiency (SRI)
    Marbury, Thomas C.
    Ticho, Barry
    Stecher, Scott
    Zhu, Ying
    Swan, Suzanne K.
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (06) : S65 - S65
12345